Once a safe and effective vaccine for COVID-19 has been discovered, there will not be enough doses for everyone at risk of infection.
Who should be prioritized? Frontline healthcare workers? Elderly residents of long-term care facilities? Members of low-income communities of color which have been disproportionately harmed by the pandemic? How should the U.S. approach the question of international distribution? Should it prioritize its citizens, engaging in “vaccine nationalism?” Or, should it pool its resources with other countries to ensure a fair distribution among low-, middle-, and high-income countries?
These questions will be explored in a fun and lively discussion moderated by Professor Douglas MacKay.
Links to the readings (three short articles) are HERE.